biosensing

BioSens8 is a Cambridge, MA-based company building continuous, non-invasive wearable biosensors that monitor hormones, metabolites, and organ health markers in real time. Its platform offers continuous cortisol and glucose monitoring to help users understand and act on stress, sleep, nutrition, exercise, and recovery, with user-owned data and algorithms that turn raw readings into personalized insights.

algorithm-based data insightsdigital healthwearables

Discovering New Possibilities in Sensing Technology Discovering New Possibilities in Sensing Technology Discovering New Possibilities in Sensing Technology Discovering New Possibilities in Sensing Technology Pioneering breakthroughs in bio- & environmental sensing to improve lives worldwide Explore Now About Bubble Senses Our Mission At Bubble Senses, our mission is to use a unique bubble-sensing technology to improve the health and well-being of people and the Earth. We are committed to developing innovative solutions to some of the most pressing healthcare and environmental challenges of our time.Our Technology Our shrinking surface bubble deposition (SSBD) technology, invented by scientists at the University of Notre Dame, uses a unique thermofliudic flow around a surface to capture, concentrate and deposit targets in liquid samples on surface to enable a variety of characterization.

electron microscopyenvironmental sensingRaman characterizationshrinking surface bubble deposition (SSBD) technologyultra-sensitive target detection in liquid samples

Effervescence Diagnostics is a healthcare technology company based in Cambridge, MA, developing next-generation diagnostic solutions to improve global health outcomes. Its VISTA platform is a smartphone-powered, microfluidic device that delivers rapid detection of viruses, pathogens, and environmental contaminants using AI-powered image analysis, designed for use at home, in clinics, communities, and crisis zones.

AI-powered image analysismicrofluidic diagnosticssmartphone integration

Elecular Technology LLC is an ASU start-up company founded in 2019, focusing on innovations of microchip platforms for high-throughput biosensing and sequencing. It has developed Quantum-NanoElectroPore (Q-NEP), an optoelectrical platform for single-molecule sensing and sequencing based on a multiplexed microchip of solid-state nanopore devices with tunable self-aligned tunneling nanogaps embedded in nanofluidic channels.

bioassay developmentmicrochip platform developmentsingle-molecule characterizationsingle-molecule detectionsingle-molecule sequencing

Emitech, Inc. is a biotechnology research and development company based in Fall River, Massachusetts, founded in 2002 by Marina Katayeva and Dr. Igor Levitsky. It specializes in nanotechnology innovations for detection and diagnostics, developing electrochemical nano-biosensors, chemosensors, and optoelectronic devices for government and private sector clients in the Life Science and Material Science markets.

chemosensingelectrochemical sensingnanotechnologyprototypingresearch and developmentsensor and device designtesting